The bill amends Section 443.205 of the Health and Safety Code to require specific labeling for consumable hemp products that contain more than trace amounts of cannabinoids. The updated requirements include a batch identification number, batch date, product name, a URL linking to a certificate of analysis, the manufacturer's name, and a certification that the delta-9 tetrahydrocannabinol (THC) concentration does not exceed 0.3 percent. Additionally, the bill introduces new warnings that must be included on the labels of these products, particularly for those intended for ingestion or topical use that contain more than 10 micrograms of THC per gram.

The new warnings address various health risks associated with cannabis consumption, including potential poisoning in children, delayed effects from ingestion, risks to brain development in individuals under 25, and the possibility of addiction and mental health disorders. For topical products, a specific warning is mandated regarding the risks of swallowing or applying the product to broken skin. The changes will apply only to consumable hemp products distributed or sold after the bill's effective date, which is set for 91 days following the end of the legislative session.

Statutes affected:
Introduced: Health and Safety Code 443.205 (Health and Safety Code 443)